Research map: Augmenting immune reconstitution after adult allo-haematopoietic stem cell transplantation: current developments and modifiable determinants

Back to the article

Papers in this map

  1. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide · Leo Luznik · 2008 · 1957 citations · Cited by this paper
  2. Bidirectional relationship between metabolic and thrombotic disease mechanisms · 2026 · Related
  3. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation · Francisco M. Marty · 2017 · 1248 citations · Cited by this paper
  4. Antithymocyte globulin and posttransplant cyclophosphamide in graft vs. host disease prophylaxis: comparison or combination · 2025 · Related
  5. Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype · Franco Aversa · 1998 · 1180 citations · Cited by this paper
  6. The role of stem cell transplantation in the modern management of multiple myeloma · 2025 · Related
  7. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation · Ying Taur · 2014 · 909 citations · Cited by this paper
  8. Clinical applications of PET imaging for evaluating treatment-induced vascular toxicity in oncology · 2026 · Related
  9. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation · Jonathan U. Peled · 2020 · 784 citations · Cited by this paper
  10. Messengers of coagulopathy: complement-carrying extracellular vesicles in SARS-CoV-2 infection · 2026 · Related
  11. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial · Jürgen Finke · 2009 · 733 citations · Cited by this paper
  12. Red cells: not only hemoglobin – plasma membranes are also of paramount importance · 2025 · Related
  13. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis · Javier Bolaños‐Meade · 2023 · 601 citations · Cited by this paper
  14. Roles of megakaryocytes and platelets in myeloproliferative neoplasms · 2026 · Related
  15. Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease · Nicolaus Martin Kröger · 2016 · 574 citations · Cited by this paper
  16. Advances in the pathophysiology and treatment of anaemia in multiple myeloma · 2026 · Related
  17. Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation · Justyna Ogonek · 2016 · 463 citations · Cited by this paper
  18. G protein-coupled receptor-mediated platelet thrombus formation · 2026 · Related
  19. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation · Ifigeneia Tzannou · 2017 · 462 citations · Cited by this paper
  20. Contemporary data in myeloproliferative neoplasm-unclassifiable: mutational landscape and management of the ‘unclassifiable’ · 2025 · Related
  21. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant · Ying Taur · 2018 · 386 citations · Cited by this paper
  22. Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial · Irwin Walker · 2015 · 370 citations · Cited by this paper
  23. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) · Catherine Cordonnier · 2019 · 334 citations · Cited by this paper
  24. Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation · Robert J. Soiffer · 2017 · 326 citations · Cited by this paper
  25. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis · Rick Admiraal · 2015 · 290 citations · Cited by this paper
  26. Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD · Benjamin K. Watkins · 2021 · 262 citations · Cited by this paper
  27. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation · Miguel‐Angel Perales · 2012 · 210 citations · Cited by this paper
  28. Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies · Leo Luznik · 2021 · 179 citations · Cited by this paper
  29. Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation · Danniel Zamora · 2021 · 171 citations · Cited by this paper
  30. Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection · Rohtesh S. Mehta · 2016 · 151 citations · Cited by this paper
  31. Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation · Rémy Duléry · 2021 · 144 citations · Cited by this paper
  32. Immune reconstitution following stem cell transplantation · Marcel R.M. van den Brink · 2015 · 130 citations · Cited by this paper
  33. Sex steroid blockade enhances thymopoiesis by modulating Notch signaling · Enrico Velardi · 2014 · 122 citations · Cited by this paper
  34. Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation: Time To T Up the Thymus · Mohammed Suhail Chaudhry · 2016 · 119 citations · Cited by this paper
  35. Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial · Domenico Russo · 2023 · 115 citations · Cited by this paper
  36. Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease · Marie Bleakley · 2022 · 106 citations · Cited by this paper
  37. Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTR · Stephen R. Spellman · 2025 · 101 citations · Cited by this paper
  38. Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial · Kris Michael Mahadeo · 2024 · 89 citations · Cited by this paper
  39. Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML · Armin Rashidi · 2023 · 80 citations · Cited by this paper

Source: OpenAlex (CC0)